TrialClinical pharmacology and therapeutics2021

Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.

Jeroen V Koomen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.